1.3. Analysis.

Comparison 1 Cabergoline versus Bromocriptine, Outcome 3 Hoehn and Yahr stage.

Hoehn and Yahr stage
Study
Gershanik 1994	'Off' state: Improvement on cabergoline ‐0.5 (SD 0.6) v bromocriptine ‐0.6 (SD 0.7) 'On' state: Improvement on cabergoline ‐0.2 (SD 0.4) v bromocriptine ‐0.3 (SD 0.5)
Gershanik 1994b	'Off' state: Improvement on cabergoline ‐0.5 (SD 0.7) v bromocriptine ‐0.4 (SD 0.6) 'On' state: Improvement on cabergoline ‐0.1 (SD 0.5) v bromocriptine ‐0.2 (SD 0.5)
Inzelberg 1996	Not available
Korczyn 1994	'Off' state: Improvement on cabergoline (n=17) ‐0.38 (SD 0.81) v bromocriptine (n=15) ‐0.23 (SD 1.02). 'On' state: Improvement on cabergoline (n=19) ‐0.16 (SD 0.55) v bromocriptine (n=15) ‐0.30 (SD 0.72).